Safety and efficacy of extended-release niacin for the treatment of dyslipidaemia in patients with HIV infection: AIDS Clinical Trials Group Study A5148.

Dubé, Michael P; Wu, Julia W; Aberg, Judith A; Deeg, Mark A; Alston-Smith, Beverly L; McGovern, Mark E; Lee, Daniel; Shriver, Sharon L; Martinez, Ana I; Greenwald, Martha; Stein, James H

Dubé, Michael P; Wu, Julia W; Aberg, Judith A; Deeg, Mark A; Alston-Smith, Beverly L; McGovern, Mark E; Lee, Daniel; Shriver, Sharon L; Martinez, Ana I; Greenwald, Martha; Stein, James H.

Affiliation

Dubé MP; Department of Medicine, Indiana University School of Medicine, Indianapolis, IN, USA. mpdube@iupui.edu

Antivir Ther ; 11(8): 1081-9, 2006.

Article in En | MEDLINE | ID: mdl-17302378

Subject(s)

Dyslipidemias/drug therapy; Dyslipidemias/etiology; HIV Infections/complications; Niacin/therapeutic use; Adult; Blood Glucose; Delayed-Action Preparations; Humans; Hypolipidemic Agents/administration & dosage; Hypolipidemic Agents/therapeutic use; Male; Middle Aged; Niacin/administration & dosage; Niacin/adverse effects; Triglycerides

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: HIV Infections / Dyslipidemias / Niacin Limits: Adult / Humans / Male / Middle aged Language: En Journal: Antivir Ther Journal subject: TERAPIA POR MEDICAMENTOS / VIROLOGIA Year: 2006 Document type: Article Affiliation country: United States

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google